Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 11, 2021

Primary Completion Date

May 17, 2022

Study Completion Date

July 12, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

BBT-401-1S or Placebo

Administered by 200mg capsules of BBT-401-1S or placebo

Trial Locations (30)

11366

Intercity Gastroentertology, Fresh Meadows

15355

Korea University Ansan Hospital, Ansan

21018

Communal Non-profit enterprise Vinnytsya city clinical hospital 1 gastroenterology department, Vinnytsia

Medical Center of LLC Oxford Medical-Vinnytsia, Vinnytsia

26426

Wonju Severance Christian Hospital, Wŏnju

28210

Javara Research, Charlotte

41404

Kyungpook National University Chilgok Hospital, Bugok

42415

Yeungnam University Hospital, Daegu

43005

Municipal Enterprise Volyn Regional Clinical Hospital of the Volyn Regional Council, Department of S, Luts'k

48108

Inje University Haeundae Paik Hospital, Haeundae

61037

Municipal Non-Profit Enterprise City Clinical Hospital No. 2 named after prof. O.O. Shalimov of the, Kharkiv

72211

Premier Gastroenterology, Little Rock

72212

Premier Gastroenterology, Little Rock

73003

Municipal Non-Profit Enterprise Kherson City Clinical Hospital named after E.E.Karabelesha of Kherso, Kherson

78503

Inves Clinic, McAllen

78660

Discovery Clinical Trials - AACT, Pflugerville

84065

Velocity Clinical Research, Riverton

84088

West Jordan, West Jordan

92708

Saini Surinder S MD, Fountain Valley

93534

Gastro Care Institute, Lancaster

85-796

Centrum Medyczne Pratia Bydgoszcz, Bydgoszcz

40-748

VITA LONGA Sp. z o.o., Katowice

50-449

Centrum Medyczne Melita Medical, Wroclaw

90-153

Uniwersytecki Szpital Kliniczny Nr. 1 im. Norberta Barlickiego, Lodz

04551

Inje University, Seoul Paik Hospital, Junggu

06591

The Catholic university of Korea, Seoul St Mary's Hospital, Seocho

01023

Medical Centre of the Limited Liability Company Medical Clinic Blagomed, Treatment and Diagnostic Di, Kyiv

01030

Communal Non-profit enterprise Kyiv City Clinical Hospital No. 18, of the executive body of the Kyiv, Kyiv

08711

Medical Center RCLIN Ukraine of the Limited Liability Company Cardiocom, Obukhiv

04078

Municipal Non-Profit Enterprise of the Kyiv Regional Council Kyiv Regional Hospital, Therapeutics De, Kyiv

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Covance

INDUSTRY

lead

Bridge Biotherapeutics, Inc.

INDUSTRY

NCT04596293 - Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis | Biotech Hunter | Biotech Hunter